C. Andrew Kistler, MD, PharmD

Andy authors Cancer Therapy Advisor's "In the Clinic" column. He is a gastroenterologist with interests in GI oncology, immunotherapy, the gut microbiome, and clinical pharmacology.

All articles by C. Andrew Kistler, MD, PharmD

Inflammatory Bowel Diseases (IBD)

Opioids and IBD: Current Challenges

C. Andrew Kistler, MD, PharmD

April 2, 2021

Initiation of opioid use during a flare of symptoms can eventually lead to chronic opioid use (COU), which can have detrimental effects on a patient’s IBD, as well as their overall clinical health.

Inflammatory Bowel Diseases (IBD)

HIV and Inflammatory Bowel Disease: A Unique Patient Population

C. Andrew Kistler, MD, PharmD

March 19, 2021

The authors review gut dysfunction and microbiota changes during HIV infection and IBD and discuss how they may induce a dysfunctional mucosal barrier, dysbiosis, and changes on the cellular level, including monocytes, macrophages, and dendritic cells.